
Eric Bishop, Vice President, R&D, Cygnus Technologies
Advertisement
Articles by Eric Bishop, Vice President, R&D, Cygnus Technologies

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Merck TROP2 ADC Meets Survival End Point in Gastroesophageal Cancer
2
Biocon’s Pebrilzo Becomes First Breast Cancer Treatment Biosimilar Approved Under EMA’s Tailored Clinical Approach
3
AbbVie and DISCO Partner on AND-Gated Bispecifics Designed to Recognize Tumor-Selective Protein Pairs
4
Celldex Ends Program for its Atopic Dermatitis Treatment After Phase 2 Miss Points to Limited Role for Mast Cells
5
